ArcaScience
Paris
About ArcaScience
ArcaScience is the only AI-native Benefit-Risk Analysis (BRA) platform, built on 23 proprietary AI models, hybridizing LLMs and encoder-based infrastructures’a breakthrough that global pharma giants failed to achieve (Roche’s Voyager, Sanofi’s Darwin, Novartis’ Data42). Nearly a spin-off of INRIA, we deliver instant, AI-driven BRA at scale, where others rely on slow, manual consulting.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $7.0M
- Funding stage: Seed
- Last round: Seed (Jun 2025)
- Website: arcascience.ai
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Information Technology, Medical, Software
Social Profiles
Canonical: https://fsome.com/organization/arcascience-3547 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.